title: Impact of CYP3A5 genetic polymorphism on pharmacokinetics of tacrolimus in healthy Japanese subjects.
authors.forename: Yoshiharu
authors.initials: Y
authors.lastname: Suzuki
authors.forename: Masato
authors.initials: M
authors.lastname: Homma
authors.forename: Kosuke
authors.initials: K
authors.lastname: Doki
authors.forename: Fumio
authors.initials: F
authors.lastname: Itagaki
authors.forename: Yukinao
authors.initials: Y
authors.lastname: Kohda
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism; D051544:Cytochrome P-450 CYP3A / Q000235:genetics*; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics*; D011110:Polymorphism, Genetic / Q000235:genetics*; D016559:Tacrolimus / Q000493:pharmacokinetics*
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D007166:Immunosuppressive Agents; C510164:CYP3A5 protein, human; D051544:Cytochrome P-450 CYP3A; D016559:Tacrolimus